| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/05/2001 | WO2001047999A1 A new polypeptide-human gonadoliberin 11 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047998A1 A novel polypeptide - ras gtpase-activating protein 12 and a polynucleotide encoding the same |
| 07/05/2001 | WO2001047997A1 A new polypeptide-stathmin protein 8 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047996A1 A NOVEL POLYPEPTIDE, Cu/Zn SOD PROTEIN FAMILY 9 AND THE POLYNUCLEOTIDE ENCODING THEREOF |
| 07/05/2001 | WO2001047995A1 A novel polypeptide - human dioxygenase 13 and a polynucleotide encoding the same |
| 07/05/2001 | WO2001047994A1 A novel polypeptide - pep-utilizing protein 10 and a polynucleotide encoding the same |
| 07/05/2001 | WO2001047993A1 A novel polypeptide - anion-exchange protein 9 and a polynucleotide encoding the same |
| 07/05/2001 | WO2001047992A1 A novel polypeptide - phosphatidyl:transferase 14 and a polynucleotide encoding the same |
| 07/05/2001 | WO2001047991A1 A novel polypeptide-glycosyl hydrolase and the polynucleotide encoding the same |
| 07/05/2001 | WO2001047990A1 A novel polypeptide - ribosomal protein l2-11 and the polynucleotide encoding the same |
| 07/05/2001 | WO2001047989A1 A novel polypeptide, gap junction protein connexin-9 and the polynucleotide encoding thereof |
| 07/05/2001 | WO2001047988A1 A novel polypeptide-dna mismatch repair protein 11 and a polynucleotide encoding the same |
| 07/05/2001 | WO2001047987A1 A novel polypeptide-sigma-54 factor 9 and the polynucleotide encoding the same |
| 07/05/2001 | WO2001047986A1 A new polypeptide-thiolase protein 11 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047985A1 A novel protein kinase c-13 and encoding sequences thereof |
| 07/05/2001 | WO2001047984A1 A novel polypeptide - protein 10 of amidase family and a polynucleotide encoding the same |
| 07/05/2001 | WO2001047983A1 A novel polypeptide - corticotrophin releasing factor 13 and a polynucleotide encoding the same |
| 07/05/2001 | WO2001047982A1 A novel polypeptide-mitochondrial carrier 30 and the polynucleotide encoding the same |
| 07/05/2001 | WO2001047981A1 NUCLEOTIDE SEQUENCES CODING FOR A POLYPEPTIDE CAPABLE OF INTERACTING WITH PROTEINS OF THE p300/CBP AND Rb |
| 07/05/2001 | WO2001047972A1 A novel polypeptide-poly isoprenyl synthetase protein 9 and polynucleotide encoding said polypeptide |
| 07/05/2001 | WO2001047971A1 A novel polypeptide - anion exchange protein 9 and polynucleotide encoding said polypeptide |
| 07/05/2001 | WO2001047968A1 A novel polypeptide-hexokinase protein 12 and polynucleotide encoding said polypeptide |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047962A2 Attenuated microorganisms for the treatment of infection |
| 07/05/2001 | WO2001047961A1 P. gingivalis antigenic composition |
| 07/05/2001 | WO2001047959A2 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/05/2001 | WO2001047956A2 Method for obtaining proteins having improved functional characteristics |
| 07/05/2001 | WO2001047955A2 Improvements in or relating to immune responses to hiv |
| 07/05/2001 | WO2001047953A2 Antibodies against plasma cells |
| 07/05/2001 | WO2001047952A2 Insecticidal proteins from bacillus thuringiensis |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2001047943A1 Antisense modulation of akt-3 expression |
| 07/05/2001 | WO2001047911A1 Cationic amphiphiles, uses and synthesis method thereof |
| 07/05/2001 | WO2001047638A2 Integrated microfluidic disc |
| 07/05/2001 | WO2001047563A1 Use of lithium (li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 07/05/2001 | WO2001047550A1 Method for treatment of canine distemper |
| 07/05/2001 | WO2001047543A2 Activation and inhibition of the immune system |
| 07/05/2001 | WO2001047541A1 Optimized minigenes and peptides encoded thereby |
| 07/05/2001 | WO2001047530A1 A method of therapy and prophylaxis of inflammation |
| 07/05/2001 | WO2001047496A1 Histidine copolymer and methods for using same |
| 07/05/2001 | WO2001047354A1 Model animal with favorite onset of rheumatoid arthritis |
| 07/05/2001 | WO2001047353A1 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes |
| 07/05/2001 | WO2001018224A8 Adenoviral vectors modified for increased and persistent expression of the cystic fibrosis transmembrane conductance regulator gene in human airway epithelia |
| 07/05/2001 | WO2001018221A8 Nucleic and amino acid sequences relating to resistance to blackleg in plants |
| 07/05/2001 | WO2001012777A3 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 07/05/2001 | WO2001011341A3 A system for cell-based screening |
| 07/05/2001 | WO2001011052A3 Monocellular or multicellular organisms for the production of riboflavin |
| 07/05/2001 | WO2001009333A3 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 07/05/2001 | WO2001009331A3 Moraxella catarrhalis antigen basb125 |
| 07/05/2001 | WO2001009330A3 Moraxella catarrhalis antigen basb121 |
| 07/05/2001 | WO2001004334A3 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 07/05/2001 | WO2001003720A9 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 07/05/2001 | WO2001002592A3 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 07/05/2001 | WO2001002563A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2001002019A3 Control of gene expression |
| 07/05/2001 | WO2001000825A3 Human chromosome 15 and 16 bardet-biedl syndrome polynucleotides and polypeptides and methods of use |
| 07/05/2001 | WO2001000824A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2001000822A3 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 07/05/2001 | WO2000078974A3 Overexpression in yeast and plants of a gene encoding glycerol 3-phosphate acyltransferase |
| 07/05/2001 | WO2000077213A3 Avirulent brucella and uses thereof |
| 07/05/2001 | WO2000077185A3 Herbicide target genes and methods |
| 07/05/2001 | WO2000075340A3 Magnesium chelatase |
| 07/05/2001 | WO2000073796A3 Ligand-anchor conjugates for producing a biosensor layer |
| 07/05/2001 | WO2000073478A3 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 07/05/2001 | WO2000073348A3 Methods and compositions for inhibiting neoplastic cell growth |
| 07/05/2001 | WO2000071679A3 Human oxidoreductase proteins |
| 07/05/2001 | WO2000071578A3 New polypeptides and their use for the rescue of fusion defective virus or retrovirus glycoproteins |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000061771A3 Transgenic plants containing altered levels of sterol compounds and tocopherols |
| 07/05/2001 | WO2000061622A3 Genes associated with diseases of the kidney |
| 07/05/2001 | WO2000061621A3 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/05/2001 | WO2000059942A3 Human obesity protein binding protrein-2 homolog and uses thereof |
| 07/05/2001 | WO2000046355A8 Telomerase reverse transcriptase transcriptional regulatory sequences |
| 07/05/2001 | WO2000034483A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/05/2001 | WO2000024246A9 Transgenic fish carrying plasmid for mutation detection and methods |
| 07/05/2001 | WO2000018799A9 Artemin, a novel neurotrophic factor |
| 07/05/2001 | WO2000017356A9 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof |
| 07/05/2001 | WO2000017334A9 Analysis of ligand activated nuclear receptors i(in vivo) |
| 07/05/2001 | WO2000006728A8 Phosphorylation effectors |
| 07/05/2001 | WO2000003022A9 Expression of herbicide tolerance genes in plant plastids |
| 07/05/2001 | WO1999051625A9 Peptides causing formation of compact structures |
| 07/05/2001 | US20010007157 Genetically transformed rose plants and methods for their production |
| 07/05/2001 | US20010007156 Hydroperoxide lyase polypeptides |
| 07/05/2001 | US20010007155 Producing transgenic potato plant cells and plants synthesizing starch with modified viscosity and phosphate content |
| 07/05/2001 | US20010007154 Materials and methods for hybrid seed production |
| 07/05/2001 | US20010007152 Obtained by immunizing transgenic mice which produce human leukocyte antigen (HLA) with tumor-associated antigens and recovering the nucleic acids encoding the T cell receptors from the cytotoxic T lymphocytes; diagnosis and therapy |
| 07/05/2001 | US20010007026 Hydrophobic interaction chromatography using packing material with functional group introduced to adsorb nucleic acids that exhibit certain hydrophobicity |
| 07/05/2001 | US20010007025 Antisense modulation of bcl-x expression |
| 07/05/2001 | US20010007022 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free N-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 07/05/2001 | US20010007021 Monoclonal antibody, antigen-binding region of which competitively inhibits immunospecific binding of monoclonal antibody produced by hybridoma R7.6.2 having ATCC accession number 13 13 13 13 to target epitope; use in organ transplants |
| 07/05/2001 | US20010007020 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/05/2001 | US20010007019 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 07/05/2001 | US20010006959 Displaying a beta-lactamase inhibitor protein on a virus, contacting the virus with a beta-lactamase binding protein target, selecting for the virus that has a higher affinity for the target and testing the beta-lactamase inhibitor protein |
| 07/05/2001 | US20010006955 Method for recombinant adeno-associated virus-directed gene therapy |
| 07/05/2001 | US20010006954 Synthetic DNA comprising a radiation responsive enhancer-promoter operatively linked to a polypeptide encoding region linked to a transcription terminating region; regulating gene expression and inhibiting tumor growth |
| 07/05/2001 | US20010006953 Genetic vaccination of fish and crustaceans against parasites, bacteria and viruses; use in aquaculture industry, for example |
| 07/05/2001 | US20010006950 Include genetic vaccine components that confer the ability to direct an immune response so as to acheive an optimal response to vaccination |
| 07/05/2001 | US20010006939 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 07/05/2001 | US20010006817 Cell delivery compositions |